Brett Drummond 1/8/26 Brett Drummond 1/8/26

Novoron Bioscience Awarded $2.5 Million NIH/NIA SBIR Grant to Accelerate Alzheimer's Drug Discovery with Human Brain Organoids

We are excited to announce that we have received a $2.5 million Small Business Innovation Research (SBIR) grant from the National Institute on Aging at the National Institutes of Health. The award will support the development and commercialization of Novoron's human brain organoid platform. The system is designed to identify potential Alzheimer's drugs that can slow or stop disease progression by blocking the spread of tau between cells.

Brett Drummond 2/24/25 Brett Drummond 2/24/25

Novoron Bioscience’s CEO, Travis Stiles, Ph.D., to Present at the 2025 Biocom Global Life Science Partnering and Investor Conference

Brett Drummond 10/9/24 Brett Drummond 10/9/24

Novoron Bioscience Welcomes Dr. David Weiner to the Board of Directors

Novoron Bioscience is excited to announce that Dr. David Weiner is the newest member of the Board of Directors.

Guest User 6/2/24 Guest User 6/2/24

Novoron Bioscience To Present at BIO 2024 Conference

Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, will be participating in a range of activities at the upcoming BIO 2024 conference.

Guest User 1/31/22 Guest User 1/31/22

Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer's Disease

Novoron Bioscience has received an NIH/NIA grant to advance its work on Alzheimer’s disease, CTE and other tauopathies.

Guest User 11/19/21 Guest User 11/19/21

Novoron Bioscience Raises $3M in Seed Financing from Two Bear Capital

Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they secured a $3 million Seed investment from Two Bear Capital (TBC).